Paul C. Redmond is CVP & Global Operations at Edwards Lifesciences Corp (EW). They have made 9 open-market trades across 1 company since 2010, most recently 2013-05-13.
CIK 0001440661
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EW | 12,534 | $1.1M |
Shares reported on the most recent Form 4, priced at the 2013-05-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EW | SELL | 2013-05-13 | 2013-05-15 | $67.35 | $337K | -4.2% | +1.0% | +1.0% |
| EW | SELL · 10b5-1 | 2012-05-07 | 2012-05-08 | $85.01 | $2.7M | -4.2% | +1.0% | +1.0% |
| EW | SELL · 10b5-1 | 2012-02-15 | 2012-02-16 | $75.00 | $180K | -4.2% | +1.0% | +1.0% |
| EW | SELL · 10b5-1 | 2012-01-10 | 2012-01-10 | $73.91 | $1.2M | -4.2% | +1.0% | +1.0% |
| EW | SELL | 2011-05-13 | 2011-05-16 | $88.64 | $3.9M | -4.2% | +1.0% | +1.0% |
| EW | SELL | 2011-05-09 | 2011-05-10 | $88.20 | $103K | -4.2% | +1.0% | +1.0% |
| EW | SELL | 2011-02-14 | 2011-02-16 | $88.65 | $124K | -4.2% | +1.0% | +1.0% |
| EW | SELL | 2011-02-07 | 2011-02-09 | $87.21 | $1.9M | -4.2% | +1.0% | +1.0% |
| EW | SELL | 2010-11-02 | 2010-11-04 | $64.21 | $2.2M | -4.2% | +1.0% | +1.0% |
| EW | SELL | 2010-02-19 | 2010-02-23 | $91.00 | $783K | -4.2% | +1.0% | +1.0% |
| EW | SELL | 2010-02-17 | 2010-02-18 | $88.80 | $1.2M | -4.2% | +1.0% | +1.0% |
| EW | SELL | 2010-02-09 | 2010-02-11 | $87.05 | $435K | -4.2% | +1.0% | +1.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.